Use of a murine cytomegalovirus K181-derived bacterial artificial chromosome as a vaccine vector for immunocontraception.
about
Cytomegalovirus antivirals and development of improved animal modelsMurine Cytomegalovirus Deubiquitinase Regulates Viral Chemokine Levels To Control Inflammation and PathogenesisFurther studies on the role of the residue 890 cysteine to tyrosine mutation in the M70 primase ORF of the temperature-sensitive mutant (tsm5) of murine cytomegalovirus.Electrochemical detection of a single cytomegalovirus at an ultramicroelectrode and its antibody anchoring.Ly49C-dependent control of MCMV Infection by NK cells is cis-regulated by MHC Class I moleculesA replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virusHerpesvirus BACs: past, present, and future.Progress toward an elusive goal: current status of cytomegalovirus vaccines.Natural killer cell dependent within-host competition arises during multiple MCMV infection: consequences for viral transmission and evolution.MCMV-mediated inhibition of the pro-apoptotic Bak protein is required for optimal in vivo replicationA cytomegalovirus-based vaccine provides long-lasting protection against lethal Ebola virus challenge after a single dose.A cytomegalovirus-based vaccine expressing a single tumor-specific CD8+ T-cell epitope delays tumor growth in a murine model of prostate cancerActivation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D LigandNonprimate models of congenital cytomegalovirus (CMV) infection: gaining insight into pathogenesis and prevention of disease in newborns.Knockout of the Host Resistance Gene Pkr Fully Restores Replication of Murine Cytomegalovirus m142 and m143 Mutants In VivoDesensitization of herpesvirus-encoded G protein-coupled receptors.Viral inhibition of BAK promotes murine cytomegalovirus dissemination to salivary glands.Laboratory strains of murine cytomegalovirus are genetically similar to but phenotypically distinct from wild strains of virus.Functional Dissection of an Alternatively Spliced Herpesvirus Gene by Splice Site MutagenesiscGAS-STING Signaling Regulates Initial Innate Control of Cytomegalovirus InfectionAbsence of frequent herpesvirus transmission in a nonhuman primate predator-prey system in the wild.The M33 chemokine receptor homolog of murine cytomegalovirus exhibits a differential tissue-specific role during in vivo replication and latency.Activation of intracellular signaling pathways by the murine cytomegalovirus G protein-coupled receptor M33 occurs via PLC-{beta}/PKC-dependent and -independent mechanismsIntranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T cells in the lung.Virus inhibition of RIP3-dependent necrosis.Murine cytomegalovirus IE3-dependent transcription is required for DAI/ZBP1-mediated necroptosis.Mouse cytomegalovirus M36 and M45 death suppressors cooperate to prevent inflammation resulting from antiviral programmed cell death pathways.Evasion of innate cytosolic DNA sensing by a gammaherpesvirus facilitates establishment of latent infection.The mouse cytomegalovirus glycoprotein m155 inhibits CD40 expression and restricts CD4 T cell responses.Specific inhibition of the PKR-mediated antiviral response by the murine cytomegalovirus proteins m142 and m143.Cytomegaloviruses inhibit Bak- and Bax-mediated apoptosis with two separate viral proteins.Gene products of the embedded m41/m41.1 locus of murine cytomegalovirus differentially influence replication and pathogenesis.Virally mediated inhibition of Bax in leukocytes promotes dissemination of murine cytomegalovirus.Continuous activity of Foxo1 is required to prevent anergy and maintain the memory state of CD8+ T cells.Infertility and Immunocontraception based on zona pellucida.Memory Inflation Drives Tissue-Resident Memory CD8 T Cell Maintenance in the Lung After Intranasal Vaccination With Murine Cytomegalovirus
P2860
Q27000998-532ABF2A-5456-49C5-B3B3-1A013ADB67C6Q28468563-AAA3E286-D867-4329-AFDC-1F7FDFA5D627Q30384947-962130A6-7918-4087-ABED-1480475D11E9Q30647288-2130358E-4056-4A2C-9F31-6BE18F5A6255Q33686132-F74EF6A3-4D70-4156-9075-B4346368D395Q34000122-65D4FAE7-C739-431C-B807-138C2A664949Q34247863-618EC105-1DB6-4052-B08E-E6AE2EC70185Q34434818-3297DCD6-53B6-4413-A707-C3537709E047Q34539825-C3E13EAF-FC03-4CD3-921E-B1FD3CAA0BDBQ34611158-7F03E25C-F9C5-4EDF-BE61-B77540100CBCQ35475259-88525213-77FE-4DB1-9C7D-0C548F44DBAFQ36005476-38956BDB-5518-404B-A298-092DA8A99922Q36210368-6CD22089-C0C5-42CD-9945-354EB230C642Q36359756-22869D25-F58B-443C-8C41-7AC2042F969DQ36434332-D278E859-3BBA-4ABF-B81F-A2DDA469E552Q36454708-80166D88-0AF1-47BD-A791-217DD493235EQ36667818-F4BD538D-5F4D-4486-BDF1-4BCBF3C8A933Q36747960-2557718A-97D6-4535-A57B-880AA82759DFQ36811873-CD3699CB-46A0-4215-835C-DEF9852BB1BCQ37182691-B84A609C-49E7-4B40-9E4B-AA2B7B53876FQ37252905-6E51CF26-2180-40F4-BF01-750C0E68CAD6Q37256740-126253BC-4C51-4F3A-97DC-3B258C28AA72Q37275085-1E65C486-C4D7-4797-8DAC-71028030F3F1Q37442017-08051276-2647-4014-8BD1-1ED8A01E9381Q39711744-77C65F1E-1F5C-4797-880E-161D91AC3533Q40162649-21090664-D218-4D25-962A-2579EA7A3C2FQ40292668-637CA4CD-0A2B-496D-94AA-AC683EF8969AQ41539920-0C6C8DE2-DC3C-4DDB-B152-3254DA70F71AQ42779654-6E85F836-49CF-4144-B599-973A68DA060BQ42806112-97D6DDB6-64F3-47A4-B717-F24DFE1D65E1Q42833134-A933896E-9FB2-4AE2-B298-12195CDE9C8DQ43052928-7BFB3AA2-E9DD-4D7C-84A0-B00C3B0954A3Q43898073-23B9EF7E-7F94-484A-B4F5-86403F1C39A7Q47560120-2E55838A-2BEF-46AB-A2C4-5A823CDF8C50Q54937723-9B749D4C-8BEA-498E-A5B3-3272B85181DAQ58781680-9A3A9217-179B-4804-8B2B-FD7AFDD077A9
P2860
Use of a murine cytomegalovirus K181-derived bacterial artificial chromosome as a vaccine vector for immunocontraception.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Use of a murine cytomegaloviru ...... ector for immunocontraception.
@ast
Use of a murine cytomegaloviru ...... ector for immunocontraception.
@en
type
label
Use of a murine cytomegaloviru ...... ector for immunocontraception.
@ast
Use of a murine cytomegaloviru ...... ector for immunocontraception.
@en
prefLabel
Use of a murine cytomegaloviru ...... ector for immunocontraception.
@ast
Use of a murine cytomegaloviru ...... ector for immunocontraception.
@en
P2093
P2860
P50
P1433
P1476
Use of a murine cytomegaloviru ...... vector for immunocontraception
@en
P2093
Geoffrey R Shellam
Malcolm A Lawson
Nicole L Harvey
Ulrich H Koszinowski
P2860
P304
P356
10.1128/JVI.79.5.2998-3008.2005
P577
2005-03-01T00:00:00Z